Edwards Lifesciences Corp. (EW): Price and Financial Metrics

EW POWR Grades

• Quality is the dimension where EW ranks best; there it ranks ahead of 94.88% of US stocks.
• The strongest trend for EW is in Stability, which has been heading down over the past 179 days.
• EW ranks lowest in Value; there it ranks in the 34th percentile.

EW Stock Summary

• EW has a higher market value than 95.55% of US stocks; more precisely, its current market capitalization is $48,306,166,776.
• EW's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 824.87 -- higher than 96.38% of US-listed equities with positive expected earnings growth.
• Price to trailing twelve month operating cash flow for EW is currently 39.65, higher than 89.15% of US stocks with positive operating cash flow.
• If you're looking for stocks that are quantitatively similar to EDWARDS LIFESCIENCES CORP, a group of peers worth examining would be JKHY, KEYS, GLW, DOX, and STLA.
• Visit EW's SEC page to see the company's official filings. To visit the company's web site, go to www.edwards.com.

EW Valuation Summary

• In comparison to the median Healthcare stock, EW's price/sales ratio is 93.62% higher, now standing at 9.1.
• EW's EV/EBIT ratio has moved down 0.2 over the prior 243 months.

Below are key valuation metrics over time for EW.

EW Growth Metrics

Its 4 year net cashflow from operations growth rate is now at 90.86%.
• Its 5 year revenue growth rate is now at 42.34%.
• Its 2 year revenue growth rate is now at 19.48%.

Over the past 34 months, EW's revenue has gone up $898,700,000.

The table below shows EW's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	5,382.4	1,218.2	1,521.9
2022-09-30	5,363.8	1,309	1,458.8
2022-06-30	5,355	1,531	1,455.4
2022-03-31	5,357.1	1,724.9	1,538.5
2021-12-31	5,232.5	1,732.1	1,503.1
2021-09-30	5,094.5	1,758.5	1,477.3

EW's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• EW has a Quality Grade of B, ranking ahead of 92.8% of graded US stocks.
• EW's asset turnover comes in at 0.681 -- ranking 53rd of 186 Medical Equipment stocks.
• ATRS, SRDX, and ANGO are the stocks whose asset turnover ratios are most correlated with EW.

The table below shows EW's key quality metrics over time.